Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Deisseroth

Showing results (21-30 of 180) with videos related to

Pageof 18
Sort By:
JAMA|June 19, 1996
OncologyV T DeVita, A B Deisseroth
Cancer Treatment and Research|January 1, 1997
Gene therapy of solid tumors and hematopoietic neoplasmsC R Bachier, A B Deisseroth
British Journal of Haematology|August 1, 1992
P53 gene mutations in acute myelogenous leukaemiaG Hu, W Zhang, A B Deisseroth
Trends in Genetics : TIG|October 1, 1992
Improved PCR sequencing with formamideW Zhang, C Reading, A B Deisseroth
Human Gene Therapy|December 1, 1994
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trialA B Deisseroth, J Kavanagh, R Champlin
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
v-abl activates embryonic globin gene expression in mouse erythroleukemia cellsA R Lopez, J Barker, A B Deisseroth
Blood|July 1, 1979
Hla-matched platelet transfusion therapy of severe aplastic anemiaG Tosato, F R Appelbaum, A B Deisseroth
The Western Journal of Medicine|March 1, 1986
Chronic myelogenous leukemia--recent advances in treatment and pathogenesisA B Deisseroth, S Purohit, A R Lopez
Blood|October 1, 1978
HLA-matched platelet transfusion therapy of severe aplastic anemiaG Tosato, F R Applebaum, A B Deisseroth
Oncogene|September 1, 1994
The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA elementW Zhang, X Y Guo, A B Deisseroth
Pageof 18

Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
JAMA|June 19, 1996
OncologyV T DeVita, A B Deisseroth
Cancer Treatment and Research|January 1, 1997
Gene therapy of solid tumors and hematopoietic neoplasmsC R Bachier, A B Deisseroth
British Journal of Haematology|August 1, 1992
P53 gene mutations in acute myelogenous leukaemiaG Hu, W Zhang, A B Deisseroth
Trends in Genetics : TIG|October 1, 1992
Improved PCR sequencing with formamideW Zhang, C Reading, A B Deisseroth
Human Gene Therapy|December 1, 1994
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trialA B Deisseroth, J Kavanagh, R Champlin
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
v-abl activates embryonic globin gene expression in mouse erythroleukemia cellsA R Lopez, J Barker, A B Deisseroth
Blood|July 1, 1979
Hla-matched platelet transfusion therapy of severe aplastic anemiaG Tosato, F R Appelbaum, A B Deisseroth
The Western Journal of Medicine|March 1, 1986
Chronic myelogenous leukemia--recent advances in treatment and pathogenesisA B Deisseroth, S Purohit, A R Lopez
Blood|October 1, 1978
HLA-matched platelet transfusion therapy of severe aplastic anemiaG Tosato, F R Applebaum, A B Deisseroth
Oncogene|September 1, 1994
The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA elementW Zhang, X Y Guo, A B Deisseroth
Pageof 18